Recombinant Staphylococcus aureus UPF0039 protein SAS0989 (SAS0989)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder

Note: We will prioritize shipping the format currently in stock. If you require a specific format, please specify this in your order notes.

Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.

Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.

Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Before opening, briefly centrifuge the vial to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can be used as a reference.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C. Lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.

The tag type will be determined during production. If you require a specific tag, please inform us, and we will prioritize its development.

Synonyms
SAS0989Putative acetyltransferase SAS0989; EC 2.3.1.-; GCN5-related N-acetyltransferase; GNAT
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-144
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Staphylococcus aureus (strain MSSA476)
Target Names
SAS0989
Target Protein Sequence
MFSKVNNQKM LEDCFYIRKK VFVEEQGVPE ESEIDEYESE SIHLIGYDNG QPVATARIRP INETTVKIER VAVMKSHRGQ GMGRMLMQAV ESLAKDEGFY VATMNAQCHA IPFYESLNFK MRGNIFLEEG IEHIEMTKKL TSLN
Uniprot No.

Target Background

Function

This protein catalyzes the transfer of an acetyl group from acetyl coenzyme A (AcCoA) to an acceptor substrate, releasing both CoA and the acetylated product.

Database Links

KEGG: sas:SAS0989

Protein Families
UPF0039 (ElaA) family

Q&A

What is the UPF0039 protein family and how is SAS0989 classified within it?

The UPF0039 designation refers to an "Uncharacterized Protein Family" that contains proteins with conserved sequences but unknown functions. SAS0989 is a member of this family found in Staphylococcus aureus. While specific functions remain to be fully elucidated, proteins in the UPF (Up-frameshift) pathway are generally involved in nonsense-mediated mRNA decay (NMD) and quality control mechanisms.

Up-frameshift (Upf) factors are known to eliminate aberrant mRNAs containing premature termination codons (PTCs) . The Upf complex facilitates the ubiquitin-dependent degradation of products derived from mRNAs containing specific PTCs, as demonstrated in studies with Saccharomyces cerevisiae . This suggests that SAS0989, as part of the UPF family, may play a role in similar quality control mechanisms in S. aureus.

What expression systems are most effective for producing recombinant SAS0989?

Based on established protocols for similar S. aureus proteins, Escherichia coli is typically the preferred expression system for recombinant production of S. aureus proteins. This approach has been successfully used for other S. aureus proteins such as Protein A, which can be expressed in E. coli with >99% purity and endotoxin levels below 0.1 EU/mg .

When using E. coli expression systems for S. aureus proteins, researchers should consider:

  • Codon optimization for E. coli

  • Selection of appropriate fusion tags (His-tag, GST, etc.) to facilitate purification

  • Optimization of induction conditions (temperature, IPTG concentration, induction time)

  • Inclusion of protease inhibitors during purification to prevent degradation

Similar to the methodology used for S. aureus Protein A, purification can be achieved through affinity chromatography followed by additional steps to ensure high purity .

How can I design functional assays to determine the potential role of SAS0989 in S. aureus?

Designing functional assays for an uncharacterized protein like SAS0989 requires a systematic approach. Based on known functions of Upf proteins and S. aureus virulence factors, the following methodological strategies are recommended:

Table 1: Functional Assay Design for SAS0989 Characterization

ApproachMethodologyExpected OutcomeRelevant Controls
Gene knockoutCRISPR-Cas9 or allelic replacementPhenotypic changes indicating functionWild-type strain, complemented mutant
Protein-protein interactionPull-down assays, yeast two-hybridIdentification of interaction partnersGST-only controls, unrelated proteins
RNA binding analysisRNA immunoprecipitation, EMSARNA targets and binding specificityNon-specific RNA, no-protein controls
Subcellular localizationFluorescent protein fusion, immunofluorescenceCellular compartment of activityKnown compartment markers
Proteomics analysisMass spectrometry after immunoprecipitationProtein complexes and modificationsIsotype control antibodies

For protein-protein interaction studies, GST pull-down experiments could be employed similar to those used for studying Upf proteins . In such experiments, GST-tagged SAS0989 can be immobilized on glutathione-Sepharose beads to identify potential binding partners from S. aureus lysates.

For functional complementation assays, you might test whether SAS0989 can complement the function of known Upf proteins in other organisms, such as the Upf1, Upf2, or Upf3 proteins studied in yeast . This approach could help establish whether SAS0989 has similar functional roles.

What purification strategies yield the highest purity and activity for recombinant SAS0989?

Purification of recombinant SAS0989 requires careful optimization to maintain protein integrity and activity. Based on successful approaches with other S. aureus proteins, the following methodology is recommended:

  • Initial Capture: Affinity chromatography using the appropriate tag (His, GST, or MBP tags are commonly used)

  • Intermediate Purification: Ion exchange chromatography to separate based on charge properties

  • Polishing Step: Size exclusion chromatography to achieve final purity and remove aggregates

When expressing S. aureus proteins in E. coli, inclusion body formation can be a challenge. If SAS0989 forms inclusion bodies, a refolding protocol may be necessary, involving solubilization with chaotropic agents (such as urea or guanidine hydrochloride) followed by controlled dilution or dialysis to remove the denaturant.

Quality control should include SDS-PAGE analysis, Western blotting, mass spectrometry, and activity assays when possible. For recombinant proteins from S. aureus, endotoxin removal is critical for downstream applications, especially immunological studies, aiming for levels below 0.1 EU/mg as achieved with other S. aureus recombinant proteins .

How can structural analysis of SAS0989 inform predictions about its function?

Understanding the structure-function relationship of SAS0989 requires a multifaceted approach. While specific structural data for SAS0989 is limited, general methodological approaches include:

  • Homology Modeling: Using known structures of related Upf proteins as templates to predict the tertiary structure of SAS0989

  • Domain Identification: Analyzing conserved domains that might suggest functional roles

  • Active Site Prediction: Identifying potential catalytic residues through conservation analysis

  • Structural Comparison: Comparing predicted structures with known functional proteins

The Upf protein family contains several conserved domains that could be relevant to SAS0989. For example, Upf2 proteins contain acidic domains and U1I domains that are important for interaction with other proteins in the surveillance complex . If SAS0989 contains similar domains, it may participate in comparable protein-protein interactions.

Crystallography or cryo-EM studies would provide definitive structural information, but in their absence, computational approaches can yield valuable insights. Molecular dynamics simulations can help predict flexibility and potential conformational changes relevant to function.

What protein interactions might suggest the functional role of SAS0989 in S. aureus?

Identification of protein interaction partners is a powerful approach to understanding the function of uncharacterized proteins like SAS0989. Research on other Upf proteins has shown that they interact with specific factors in the translation termination complex.

For instance, Upf2p and Upf3p interact with eRF3 (a translation termination factor) with affinity similar to Upf1p, as demonstrated through GST pull-down experiments . These interactions are specific and direct, with approximately 10% of input Upf proteins being pulled down by GST-eRF3 .

Based on this information, SAS0989 might interact with S. aureus translation machinery components. Methodological approaches to identify such interactions include:

  • Co-immunoprecipitation: Using antibodies against SAS0989 to pull down protein complexes

  • Proximity-dependent Biotin Identification (BioID): Identifying nearby proteins in living cells

  • Yeast Two-Hybrid Screening: Systematic identification of binary protein interactions

  • Crosslinking Mass Spectrometry: Capturing transient interactions through chemical crosslinking

These approaches could reveal whether SAS0989 participates in translation quality control mechanisms similar to other Upf proteins, or whether it has distinct roles in S. aureus biology.

How is SAS0989 expression regulated in different growth conditions and infection models?

Understanding the regulation of SAS0989 expression requires examining its transcription and translation under various conditions. A comprehensive methodological approach would include:

Table 2: Methods for Analyzing SAS0989 Expression Regulation

MethodApplicationData OutputAdvantages
qRT-PCRmRNA quantificationRelative expression levelsHigh sensitivity, quantitative
RNA-SeqTranscriptome analysisExpression patterns, co-expressed genesGenome-wide perspective
Western blottingProtein quantificationProtein levels, post-translational modificationsSpecific protein detection
Promoter fusion reportersPromoter activityExpression patterns in various conditionsIn vivo monitoring capability
ChIP-SeqTranscription factor bindingRegulatory elements, binding sitesIdentifies direct regulators

When designing experiments to study SAS0989 regulation, it's important to test various conditions relevant to S. aureus pathogenesis, including:

  • Different growth phases (lag, exponential, stationary)

  • Nutrient limitation conditions

  • Antibiotic stress

  • Host-mimicking conditions (serum, low pH, etc.)

  • Biofilm versus planktonic growth

This approach would help identify the stimuli and regulatory networks that control SAS0989 expression, providing insights into its potential function during infection or colonization.

What phenotypes are associated with SAS0989 knockout or overexpression in S. aureus?

Genetic manipulation studies are crucial for understanding protein function. For SAS0989, the following methodological approaches would be informative:

  • Gene Deletion: Create a clean deletion mutant of SAS0989 using allelic replacement or CRISPR-Cas9

  • Complementation: Reintroduce SAS0989 in the deletion mutant to confirm phenotype restoration

  • Controlled Overexpression: Express SAS0989 under inducible promoters to assess dose-dependent effects

  • Domain Mutations: Introduce specific mutations in predicted functional domains

Phenotypic assays should evaluate:

  • Growth characteristics in various media

  • Stress tolerance (oxidative, acid, antimicrobial)

  • Biofilm formation capacity

  • Virulence factor production

  • Host cell interactions (adhesion, invasion, survival)

  • Virulence in animal infection models

Studies with other S. aureus proteins have shown that recombinant expression proteins can induce protective immune responses in mouse models . Similar approaches could be used to assess whether SAS0989 plays a role in host-pathogen interactions or immune modulation.

How might SAS0989 contribute to S. aureus pathogenesis or antimicrobial resistance?

Investigating the potential role of SAS0989 in pathogenesis requires systematic characterization in relevant infection models. Based on studies of other S. aureus proteins, several methodological approaches are recommended:

  • Virulence Assessment: Compare the virulence of wild-type and SAS0989 mutant strains in animal infection models

  • Immune Response Analysis: Evaluate how SAS0989 affects host immune recognition and response

  • Antibiotic Susceptibility Testing: Determine whether SAS0989 influences resistance to various antibiotics

  • Stress Response Characterization: Assess the role of SAS0989 in bacterial adaptation to host environments

Other S. aureus proteins, such as Protein A, have been shown to play important roles in pathogenesis by inhibiting host immune responses . Protein A possesses five immunoglobulin-binding domains that capture both the Fc region and the Fab region of immunoglobulins, protecting S. aureus from phagocytic killing . If SAS0989 has similar immunomodulatory functions, it could be a potential target for therapeutic intervention.

What bioinformatic approaches can help predict the function of uncharacterized proteins like SAS0989?

Computational methods provide valuable insights for uncharacterized proteins when experimental data is limited. For SAS0989, the following methodological approaches are recommended:

Table 3: Bioinformatic Approaches for Functional Prediction of SAS0989

ApproachMethodOutputResources
Sequence AnalysisMultiple sequence alignment, conserved motif identificationEvolutionary relationships, functional domainsBLAST, Pfam, SMART
Structural PredictionHomology modeling, ab initio modeling3D structure modelsI-TASSER, AlphaFold, Phyre2
Gene ContextGenomic neighborhood analysisFunctional associations, operonsSTRING, GeConT
Network AnalysisProtein-protein interaction predictionFunctional clusters, pathway involvementSTRING, GeneMANIA
Phylogenetic ProfilingCo-occurrence patterns across speciesFunctional relationshipsPhyloPro, CLIME

The integration of these approaches can provide a comprehensive functional hypothesis for SAS0989. For example, if SAS0989 shows sequence similarity to RNA-binding domains found in other Upf proteins, and its gene is located near other genes involved in RNA processing or quality control, this would strengthen the hypothesis that it functions in RNA surveillance pathways.

How can I resolve solubility issues when expressing recombinant SAS0989?

Solubility challenges are common when expressing recombinant bacterial proteins. For SAS0989, the following methodological troubleshooting approaches are recommended:

  • Fusion Tag Optimization: Test different fusion partners (MBP, SUMO, TRX) known to enhance solubility

  • Expression Conditions: Optimize temperature (typically lower temperatures improve solubility), inducer concentration, and induction timing

  • Host Strain Selection: Evaluate specialized E. coli strains designed for problematic protein expression

  • Co-expression Strategies: Co-express with chaperones (GroEL/ES, DnaK/J) to aid folding

  • Buffer Optimization: Screen different buffers, salt concentrations, and additives during purification

If SAS0989 forms inclusion bodies despite optimization efforts, refolding protocols can be employed. The von Hippel-Lindau (VHL) protein, which was used as a model unfolded protein in Upf factor studies, could provide insights into handling difficult-to-fold proteins .

How do I interpret conflicting results from different functional assays for SAS0989?

When facing contradictory results from different experimental approaches, a systematic troubleshooting and integration strategy is essential:

  • Validation of Assay Specificity: Confirm that each assay is specifically measuring the intended parameter

  • Control Analysis: Review positive and negative controls to ensure assay functionality

  • Condition Comparison: Assess whether differences in experimental conditions could explain discrepancies

  • Independent Verification: Use alternative methods to confirm key findings

  • Integrated Analysis: Develop models that can accommodate seemingly contradictory results

For example, if protein-protein interaction studies suggest SAS0989 interacts with ribosomes, but subcellular localization shows cytoplasmic distribution, this apparent contradiction might be resolved by considering dynamic interactions or condition-dependent associations.

The interactions between Upf proteins and translation machinery components provide a useful reference. Research has shown that Upf proteins can associate with ribosomes in a manner dependent on specific features like a "faux 3'-UTR" . Similar context-dependent interactions might explain conflicting results with SAS0989.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.